Publications

Latest publication 02/18/2020

Multifunctional 6-fluoro-3-[3--pyrrolidin-1-yl-propyl]-1-2-benzoxazoles targetin

Patients suffering from dementia experience cognitive deficits and 90% of them show non-cognitive behavioral and psychological symptoms of dementia...

Array
(
    [id_prestablog_news] => 1230
    [id_shop] => 1
    [date] => 2020-02-18 00:00:00
    [date_modification] => 2024-02-09 14:15:12
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [prim_key] => 2417
    [id_lang] => 1
    [title] => Multifunctional 6-fluoro-3-[3--pyrrolidin-1-yl-propyl]-1-2-benzoxazoles targetin
    [paragraph] => Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD)
    [content] => 
Authors
A Bucki, M Marcinkowska, J _niecikowska, A Zagórska et al

 Lab
Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland.
Journal
European Journal of Medicinal Chemistry
Abstract
Patients suffering from dementia experience cognitive deficits and 90% of them show non-cognitive behavioral and psychological symptoms of dementia (BPSD). The spectrum of BPSD includes agitation, depression, anxiety and psychosis. Antipsychotics, e.g. quetiapine, have been commonly used off-label to control the burdensome symptoms, though they cause serious side effects and further cognitive impairment. Therefore, the development of targeted therapy for BPSD, suitable for elderly patients, remains relevant.
A multitarget-directed ligand, acting on serotonin 5-HT2A and dopamine D2 receptors (R) and thus exerting anti-aggressive and antipsychotic activity, as well as on 5-HT6Rs and 5-HT7Rs (potential pro-cognitive, antidepressant and anxiolytic activity), poses a promising strategy for the treatment of BPSD. Antitargeting muscarinic M3R and hERG channel is expected to reduce the risk of side effects. We obtained a series of stereoisomeric compounds by combining 6-fluoro-1,2-benzoxazole moiety and arylsulfonamide fragment through pyrrolidin-1-yl-propyl linker.
N-[(3R)-1-[3-(6-fluoro-1,2-benzoxazol-3-yl)propyl]pyrrolidin-3-yl]-1-benzothiophene-2-sulfonamide showed a substantial affinity for the targets of interest (pKi = 8.32–9.35) and no significant interaction with the antitargets. Functional studies revealed its antagonist efficacy (pKB = 7.41–9.03). The lead compound showed a promising profile of antipsychotic-like activity in amphetamine- and MK-801-induced hyperlocomotion (MED = 2.5 mg/kg), antidepressant-like, as well as anxiolytic-like activity in mice (MED = 0.312 and 1.25 mg/kg in the forced swim and four-plate tests, respectively). Notably, the novel compound didn’t affect spontaneous locomotor activity, nor induced catalepsy or memory deficits (step-through passive avoidance test) in therapeutically relevant doses, which proved its benign safety profile. The overall pharmacological characteristics of the lead compound outperformed the reference drug quetiapine, making it a promising option for evaluation in the treatment of BPSD.
BIOSEB Instruments Used
Aron Test or Four Plates Test (LE830),Passive avoidance (LE870)
    [meta_description] => 
    [meta_keywords] => https://www.sciencedirect.com/science/article/pii/S0223523420301161
    [meta_title] => 
    [link_rewrite] => multifunctional-6-fluoro-3-3--pyrrolidin-1-yl-propyl-1-2-benzoxazoles-targeting-behavioral-and-psychological-symptoms-of-dementia--bpsd-
    [actif_langue] => 1
    [read] => 128
    [count_comments] => 0
    [id] => 1230
    [categories] => Array
        (
            [60] => Array
                (
                    [id_prestablog_categorie] => 60
                    [title] => Cognitive performance
                    [link_rewrite] => Cognitive-performance
                )

            [16] => Array
                (
                    [id_prestablog_categorie] => 16
                    [title] => Other disorders
                    [link_rewrite] => Other-disorders
                )

            [2] => Array
                (
                    [id_prestablog_categorie] => 2
                    [title] => Publications
                    [link_rewrite] => publications
                )

        )

    [authors] => 
    [paragraph_crop] => Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral [...]
    [link_for_unique] => 1
    [products_liaison] => Array
        (
            [588] => Array
                (
                    [name] => Aron Test or Four Plates Test
                    [description_short] => 
The Four Plates Test is an exclusivity from BIOSEB!
The Aron test allows a quick characterization of putative anxiolytics compounds in naïve animals. A must for studying anxiety, drug screening and phenotyping.
                    [thumb] => 
                    [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
                    [image_presente] => 1
                    [link] => https://bioseb.com/en/anxiety-depression-disorder/588-aron-test-or-four-plates-test.html
                )

            [519] => Array
                (
                    [name] => Passive avoidance
                    [description_short] => Fear-motivated tests classically used to assess short-term or long-term memory on small laboratory animals
                    [thumb] => 
                    [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
                    [image_presente] => 1
                    [link] => https://bioseb.com/en/learningmemory-attention-addiction/519-passive-avoidance.html
                )

        )

)
1